BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St set for higher open after Micron revives AI optimism, upbeat economic data
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Biolase (BIOL) Reports Q4 EPS of ($0.03)
March 17, 2022 4:11 PM EDTBiolase (NASDAQ: BIOL) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $11.97 million.
For earnings history and earnings-related data on Biolase (BIOL) click here.
... More